Is Vivani Medical Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: VANI) stock is to Buy VANI stock.
Out of 1 analyst, 0 (0%) are recommending VANI as a Strong Buy, 1 (100%) are recommending VANI as a Buy, 0 (0%) are recommending VANI as a Hold, 0 (0%) are recommending VANI as a Sell, and 0 (0%) are recommending VANI as a Strong Sell.
What is VANI's earnings growth forecast for 2025-2025?
(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 46.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.
Vivani Medical's earnings in 2025 is -$23,486,000.
In 2025, VANI is forecast to generate -$21,919,874 in earnings, with the lowest earnings forecast at -$21,919,874 and the highest earnings forecast at -$21,919,874.
What is VANI's forecast return on equity (ROE) for 2025-2026?
(NASDAQ: VANI) forecast ROE is N/A, which is considered weak.
What is VANI's Price Target?
According to 1 Wall Street analyst that have issued a 1 year VANI price target, the average VANI price target is $4.00, with the highest VANI stock price forecast at $4.00 and the lowest VANI stock price forecast at $4.00.
The Wall Street analyst predicted that Vivani Medical's share price could reach $4.00 by Apr 16, 2026. The average Vivani Medical stock price prediction forecasts a potential upside of 292.16% from the current VANI share price of $1.02.
What is VANI's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: VANI) Vivani Medical's current Earnings Per Share (EPS) is -$0.43. In 2025, VANI's EPS is forecast to hit -$0.37 (min: -$0.37, max: -$0.37).
What is VANI's forecast return on assets (ROA) for 2025-2026?
(NASDAQ: VANI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 1,136.33%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.